FDA Approved: ILLUCCIX — Original Application (Telix Pharmaceuticals (US) Inc.)

View source ↗

Summary

FDA approves the original application for ILLUCCIX, a kit to prepare Gallium-68 gozetotide injection for PET imaging of neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• ILLUCCIX (Kit for the preparation of gallium Ga-68 gozetotide injection)

Snippet

ORIG AP for ILLUCCIX (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE INJECTION)